
Editors’ Picks, April 2024: Targeting Metabolism, KRAS, and More
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
2023 is upon us, but before we dive into the new year, let’s look back at the featured articles...